Keap1–Nrf2 Signaling: A Target for Cancer Prevention by Sulforaphane
Thomas W. Kensler(Johns Hopkins University), Paul Talalay(Johns Hopkins Medicine), Abena S. Agyeman(Johns Hopkins University), John D. Groopman(Johns Hopkins University), Patricia A. Egner(Johns Hopkins University), Kala Visvanathan(St. Elizabeth's Hospital), Jianguo Chen(Qidong Liver Cancer Prevention Research), Tao-Yang Chen(Qidong Liver Cancer Prevention Research), Jed W. Fahey(Johns Hopkins University)
Cited by 354
Related Papers
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity
|Nature Genetics|2001|734
Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma
|The Lancet|1992|731
Aflatoxin: A 50-Year Odyssey of Mechanistic and Translational Toxicology
|Toxicological Sciences|2010|677